The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A PBMC and machine learning based biomarker signature to predict second line chemotherapy success in advanced PDAC: Translational data of the PREDICT trial—A prospective, multicenter, trial of the AIO Pancreatic Cancer Group (AIO-PAK-0216).
 
Anton Lahusen
No Relationships to Disclose
 
Manfred Lutz
Research Funding - SERVIER (Inst)
 
Meinolf Karthaus
No Relationships to Disclose
 
Martina Kirchner
No Relationships to Disclose
 
Klaus Kluck
No Relationships to Disclose
 
Sarah Wisser
No Relationships to Disclose
 
Phyllis Fung-Yi Cheung
No Relationships to Disclose
 
Nikolaus Ansorge
No Relationships to Disclose
 
Christof Burkart
Consulting or Advisory Role - MSD
 
Thomas Decker
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Thomas Geer
No Relationships to Disclose
 
Anke Gerhardt
No Relationships to Disclose
 
Jan Budczies
No Relationships to Disclose
 
Jens Siveke
Stock and Other Ownership Interests - FAPi Holding AG
Consulting or Advisory Role - AstraZeneca; AstraZeneca (Inst); Bayer; Bristol-Myers Squibb/Celgene; Falk Foundation; Immunocore; MCI Deutschland; MSD; MSD; Novartis; Roche; SERVIER
Research Funding - Abalos Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisbach Bio (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Andrea Tannapfel
No Relationships to Disclose
 
Thomas Seufferlein
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Falk Foundation; MSD Oncology; Pierre Fabre; SERVIER; Takeda
Consulting or Advisory Role - BioNTech SE; Boehringer Ingelheim; Cantargia AB; Mirati Therapeutics; Olympus Medical Systems; Pierre Fabre; Scandion Oncology; SERVIER
Research Funding - Lilly/ImClone (Inst)
Travel, Accommodations, Expenses - Takeda
 
Albrecht Stenzinger
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Illumina; Incyte; Janssen; Lilly; MSD; Novartis; SERVIER; Takeda; Thermo Fisher Scientific
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Illumina; MSD; Novartis; Roche; SERVIER; Thermo Fisher Scientific
Research Funding - Bayer; Bristol-Myers Squibb; Chugai Pharma; Incyte
 
Tim Eiseler
No Relationships to Disclose
 
Thomas Ettrich
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Takeda
Research Funding - Baxalta/Shire; Lilly (Inst)
Travel, Accommodations, Expenses - Ipsen; Lilly